A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.
about
Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspectiveBig opportunities for small molecules in immuno-oncology.Tackling the cancer stem cells - what challenges do they pose?The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin.Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functionsMolecular inhibition of prostaglandin E2 with GW627368X: Therapeutic potential and preclinical safety assessment in mouse sarcoma model.Association of EP2 receptor and SLC19A3 in regulating breast cancer metastasis.An inflammatory mediator, prostaglandin E2, in colorectal cancer.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.Breaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers.Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo.Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity.COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway.The Adjuvant Nutritional Intervention in Cancer (ANICA) Trial.Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy.Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4.COX-2 induces oncogenic micro RNA miR655 in human breast cancer.EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
P2860
Q34180695-3269A400-E638-45D0-9238-82A313CFDC22Q34487689-AB9E9749-E7F0-429B-9FA9-1D961A573B47Q34523263-3258D1BC-CC7C-4DFF-BC0E-769AB4247943Q34619895-7B52EE33-F1E3-414A-89AF-7AAF6EF72E7EQ35713568-D2CD5CC3-DB98-4520-BD84-C0F9995A3161Q36215333-EC59E923-69EA-4163-A3A8-11C04C00763DQ36420170-E579F012-D9BC-482E-B3D3-D77F7879C026Q36701908-7E04E822-DEAA-4753-9615-5DBB2EB611F8Q37079141-BE9C2EF6-D31D-418F-8E37-B57C595A3A36Q37470737-110CA85B-F338-44A4-A5C5-6EB89DBF8F65Q38237483-769A63CC-CF52-44A2-A2B0-97E14A1F369FQ38730382-2D0A01D5-F9F7-4E7D-A850-3A7DA4D82CF3Q39834032-0CA0DFA4-923C-4C01-A646-725C837CEE28Q40855155-E3F5CEF8-CC77-43C2-836C-5FEEB128A008Q41209794-20CB2506-B443-4ABE-813A-FA42806D0C4EQ43258268-16F7311A-37EF-4FAE-9992-F7D524D72AA0Q47166524-43425B24-ACC9-47D9-8558-0D4341266097Q49092861-F14FB340-EB11-4C58-9227-03A50E562555Q49409776-EFBA847E-4D13-4016-9D20-D11B407A2175Q53176610-78736148-10E3-4B01-9E2B-A8282C97CE3A
P2860
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@ast
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@en
type
label
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@ast
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@en
prefLabel
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@ast
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@en
P2093
P2860
P356
P1433
P1476
A prostaglandin E (PGE) recept ...... bits breast cancer metastasis.
@en
P2093
Amy M Fulton
Jocelyn Reader
Namita Kundu
Olga Goloubeva
Xinrong Ma
Yukinori Take
P2860
P304
P356
10.4161/ONCI.22647
P577
2013-01-01T00:00:00Z